172 related articles for article (PubMed ID: 23595378)
1. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy.
Wang D; Wu M; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Chin Med J (Engl); 2013; 126(8):1464-8. PubMed ID: 23595378
[TBL] [Abstract][Full Text] [Related]
2. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
3. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
Yu J; Huang L; Dong T; Cao L
J Obstet Gynaecol; 2024 Dec; 44(1):2361858. PubMed ID: 38864403
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
5. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
[TBL] [Abstract][Full Text] [Related]
8. Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
Uegaki K; Shimada M; Sato S; Deura I; Naniwa J; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2014 Apr; 19(2):348-53. PubMed ID: 23592280
[TBL] [Abstract][Full Text] [Related]
9. Assessment of primary radical hysterectomy and neoadjuvant chemotherapy followed by radical hysterectomy in Stage IB2, IIA bulky cervical cancer.
Musaev A; Guzel AB; Khatib G; Gulec UK; Vardar MA; Altintas A; Gumurdulu D
Eur J Gynaecol Oncol; 2015; 36(5):579-84. PubMed ID: 26513887
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
Zou T; Zheng C; Zhang Z; Yu L; Fu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
[TBL] [Abstract][Full Text] [Related]
12. Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy.
Watari H; Kanuma T; Ohta Y; Hassan MK; Mitamura T; Hosaka M; Minegishi T; Sakuragi N
Pathol Oncol Res; 2010 Sep; 16(3):345-52. PubMed ID: 20058210
[TBL] [Abstract][Full Text] [Related]
13. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
[TBL] [Abstract][Full Text] [Related]
14. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
18. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
Prueksaritanond N; Chaisarn P; Yanaranop M
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
